“As NeuroSigma continues to grow and work with our partners at Ignis, China will be a critical market for the Monarch eTNS System,” said Colin Kealey, M.D., President and CEO of NeuroSigma. “This ...

Feeling unusually tired? Experiencing memory fogginess? Or perhaps a strange tingling sensation in your toes? While these ...

Genome editing technologies such as CRISPR/Cas9, base editing, and prime editing are rapidly transforming our ability to ...

The European Medicines Agency's safety committee has concluded that a potentially dangerous eye condition is a very rare side effect of Novo Nordisk's popular treatments Ozempic and Wegovy, it said on ...